Literature DB >> 22346260

Dapsone Hypersensitivity Syndrome That Occurred during Treatment of Pediatric Patient with Erythema Elevatum Diutinum.

Gun-Wook Kim1, Hyun-Je Park, Hoon-Soo Kim, Su-Han Kim, Hyun-Chang Ko, Byung-Soo Kim, Moon-Bum Kim.   

Abstract

Herein, we report a case of an 8-year-old girl with dapsone hypersensitivity syndrome (DHS) that occurred during the treatment of erythema elevatum diutinum. She had fever, gross hematuria, and malaise for three weeks after initiation of dapsone therapy. Five days after stopping dapsone treatment, she returned to the emergency clinic because of high fever, emesis, diarrhea, upper respiratory symptoms, and worsening of exanthematous eruptions. A diagnosis of DHS was made, and it improved with oral prednisone. We recommend that pediatric patients who are treated with dapsone need to be observed carefully for the development of DHS.

Entities:  

Keywords:  Dapsone; Drug hypersensitivity syndrome; Erythema elevatum diutinum

Year:  2011        PMID: 22346260      PMCID: PMC3276779          DOI: 10.5021/ad.2011.23.S3.S290

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  13 in total

Review 1.  Erythema elevatum diutinum.

Authors:  L E Gibson; R A el-Azhary
Journal:  Clin Dermatol       Date:  2000 May-Jun       Impact factor: 3.541

Review 2.  Reinstatement of dapsone following hypersensitivity.

Authors:  Javier Labandeira; Jaime Toribio
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

3.  Dapsone hypersensitivity syndrome.

Authors:  R Prussick; N H Shear
Journal:  J Am Acad Dermatol       Date:  1996-08       Impact factor: 11.527

Review 4.  Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.

Authors:  J P Uetrecht
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

5.  Erythema elevatum diutinum: clinical, histopathologic, and immunohistochemical characteristics of six patients.

Authors:  Carter E Wahl; Molly B Bouldin; Lawrence E Gibson
Journal:  Am J Dermatopathol       Date:  2005-10       Impact factor: 1.533

6.  Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.

Authors:  M J Rieder; J Uetrecht; N H Shear; M Cannon; M Miller; S P Spielberg
Journal:  Ann Intern Med       Date:  1989-02-15       Impact factor: 25.391

7.  Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy.

Authors:  J H Richardus; T C Smith
Journal:  Lepr Rev       Date:  1989-12       Impact factor: 0.537

8.  Severe dapsone hypersensitivity syndrome.

Authors:  O Sener; L Doganci; M Safali; B Besirbellioglu; F Bulucu; A Pahsa
Journal:  J Investig Allergol Clin Immunol       Date:  2006       Impact factor: 4.333

9.  Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.

Authors:  Yi-Shuan Sheen; Chia-Yu Chu; Shiou-Han Wang; Tsen-Fang Tsai
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

Review 10.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

View more
  1 in total

1.  Severe dapsone hypersensitivity syndrome in a child.

Authors:  So Yoon Choi; Ho Yeon Hwang; Jung Hyun Lee; Jae Sun Park; Min Soo Jang
Journal:  Korean J Pediatr       Date:  2013-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.